ArticleCancer medicine2020

A genome-scale CRISPR knock-out screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling.

Matthieu Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.